Movement disorders : official journal of the Movement Disorder Society · 2026
RNA Toxicity and Interacting RNA-Binding Protein NOVA2 of (UUUCA)exp RNA Foci in Familial Cortical Myoclonic Tremor with Epilepsy.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhang Fan, Chen Yiling, Chen Shuqi, Xia Haibin, Zhang Yiying, Chen Xinhui, Wang Bo, Ji Junfeng, Cen Zhidong, Luo Wei
Аннотация
BACKGROUND: Familial cortical myoclonic tremor with epilepsy (FCMTE) is an autosomal dominant neurological disease characterized by cortical myoclonic tremor and epileptic seizures. The proposed pathogenic (TTTCA) pentanucleotide repeat expansion (exp) insertion, flanking the polymorphic (TTTTA)exp, has been reported in seven distinct FCMTE causative genes/loci, and a repeat motif-specific phenotype correlation is claimed. However, the pathogenic mechanism of FCMTE is still poorly understood.
METHODS: We investigated how the (TTTCA)exp insertion causes the disease, mainly employing the FCMTE1 patients-induced pluripotent stem cell-derived neurons (iPSC-neurons), focusing on the formation of (UUUCA)exp RNA foci and their associated cellular toxicity.
RESULTS: First, (TTTCA)exp insertion neither altered SAMD12 expression nor translates into repeat peptides. Second, (UUUCA)exp RNA foci were detected in both the constructed cell line and iPSC-neurons, and presented toxicity effects. Third, NOVA2, a neuron-specific splicing regulator, was identified as the key RNA-binding protein interacting with (UUUCA)exp RNA. The (UUUCA)exp RNA disrupted the nuclear distribution pattern of NOVA2, and reciprocally, knockdown of NOVA2 promoted the formation of (UUUCA)exp RNA foci. Shared synaptic-related pathways of alternative splicing events were observed in both FCMTE1-iPSC-neurons and NOVA target genes.
CONCLUSIONS: These findings support a repeat motif-dependent mechanism involving (UUUCA)exp RNA foci and the functional disruption of the key RNA-binding protein NOVA2, providing valuable insights for future studies on FCMTE and other pentanucleotide repeat expansion diseases. © 2026 International Parkinson and Movement Disorder Society.
METHODS: We investigated how the (TTTCA)exp insertion causes the disease, mainly employing the FCMTE1 patients-induced pluripotent stem cell-derived neurons (iPSC-neurons), focusing on the formation of (UUUCA)exp RNA foci and their associated cellular toxicity.
RESULTS: First, (TTTCA)exp insertion neither altered SAMD12 expression nor translates into repeat peptides. Second, (UUUCA)exp RNA foci were detected in both the constructed cell line and iPSC-neurons, and presented toxicity effects. Third, NOVA2, a neuron-specific splicing regulator, was identified as the key RNA-binding protein interacting with (UUUCA)exp RNA. The (UUUCA)exp RNA disrupted the nuclear distribution pattern of NOVA2, and reciprocally, knockdown of NOVA2 promoted the formation of (UUUCA)exp RNA foci. Shared synaptic-related pathways of alternative splicing events were observed in both FCMTE1-iPSC-neurons and NOVA target genes.
CONCLUSIONS: These findings support a repeat motif-dependent mechanism involving (UUUCA)exp RNA foci and the functional disruption of the key RNA-binding protein NOVA2, providing valuable insights for future studies on FCMTE and other pentanucleotide repeat expansion diseases. © 2026 International Parkinson and Movement Disorder Society.